Bausch Health Companies | VRX - Debt

Stock Price
7.62
Daily Change
-0.07 -0.91%
Monthly
8.55%
Yearly
1.74%
Q2 Forecast
7.53

Bausch Health Companies reported $21.04B in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Amgen USD 54.59B 1.62B Sep/2025
ANI Pharmaceuticals USD 617.04M 3.28M Dec/2025
Aurora Cannabis CAD 100.34M 1.29M Sep/2025
Bausch Health Companies USD 21.04B 696M Sep/2025
Biogen USD 6.29B 1.7M Dec/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Canopy Growth CAD 259.33M 68.47M Sep/2025
Corcept Therapeutics USD 6.36M 247K Sep/2025
Danaher USD 18.48B 66M Mar/2026
Drreddys Laboratories INR 67.73B 19.09B Dec/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Gilead Sciences USD 24.94B 5M Dec/2025
Nektar Therapeutics USD 0 0 Jun/2022
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Pacira USD 372.19M 4.53M Dec/2025
Perrigo USD 3.64B 7.2M Sep/2025
Phibro Animal Health USD 474.17M 730K Sep/2024
Prestige Brands USD 1.04B 1.7M Sep/2025
Supernus Pharmaceuticals USD 42.21M 10.44M Sep/2025
Vertex Pharmaceuticals USD 1.83B 307.4M Sep/2025
Zoetis USD 7.27B 482M Sep/2025